Allianz Asset Management
DTIL icon

Allianz Asset Management’s Precision BioSciences DTIL Stock Holding History

Allianz Asset Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,452
Closed -$263K – 2423
2020
Q1 		$263K Buy
+1,452
New +$380K ﹤0.01% 2249

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Allianz Asset Management's DTIL Position: Q2 2020 in Review

Allianz Asset Management sold out of Precision BioSciences (DTIL) in Q2 2020, closing a stake of 1,452 shares — an estimated $263K sold.

Allianz Asset Management first reported a position in DTIL in Q1 2020 and held it in 1 quarter. The position peaked at $263K in Q1 2020. 115 funds tracked by Wall St. Rank hold DTIL as of Q2 2020.

  • Allianz Asset Management reported no remaining Precision BioSciences position as of Q2 2020 after selling out during the quarter.
  • Allianz Asset Management sold 1,452 Precision BioSciences shares in Q2 2020, an estimated $263K.
  • Allianz Asset Management first reported a position in Precision BioSciences in Q1 2020 and held it in 1 quarter.
  • Allianz Asset Management's Precision BioSciences position peaked at $263K in Q1 2020.
  • 115 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2020.

Based on Allianz Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.